Revumenib in Patients With Myelofibrosis

Clinical trial NCT07734077 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07734077
Sponsor: John Mascarenhas
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis

Start date: 2026-12-01
Primary completion: 2028-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.